Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
158.00
-0.25 (-0.16%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 29, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,959,988
Open
158.98
Bid (Size)
156.39 (1)
Ask (Size)
159.55 (1)
Prev. Close
158.25
Today's Range
156.36 - 159.70
52wk Range
134.09 - 175.91
Shares Outstanding
N/A
Dividend Yield
3.29%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbbVie Unusual Options Activity
March 29, 2023
Via
Benzinga
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
March 29, 2023
These stocks look reasonably priced considering their future prospects.
Via
The Motley Fool
Performance
YTD
-2.70%
-2.70%
1 Month
+2.41%
+2.41%
3 Month
-2.61%
-2.61%
6 Month
+9.27%
+9.27%
1 Year
-2.58%
-2.58%
More News
Read More
Better Growth Stock: AbbVie vs. Pfizer
March 29, 2023
Via
The Motley Fool
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
March 28, 2023
Via
Benzinga
2 Relatively Safe Dividend Stocks You Won't Regret Owning
March 28, 2023
Via
The Motley Fool
This Is the Best Dividend ETF You Can Buy
March 28, 2023
Via
The Motley Fool
Is Big Pharma Coming For Your Cannabis Business?
March 27, 2023
Via
Benzinga
Better Buy: AbbVie vs. Johnson & Johnson
March 25, 2023
Via
The Motley Fool
AbbVie Unusual Options Activity
March 23, 2023
Via
Benzinga
2 Reasons to Buy AbbVie, and 1 Reason to Sell
March 23, 2023
Via
The Motley Fool
BioNTech Is Ripe For A Rebound In 2023
March 27, 2023
Via
MarketBeat
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
I Own 12 High-Yield Dividend Stocks. Here's the Best of the Bunch.
March 25, 2023
Via
The Motley Fool
This Delivery Giant Is A 'Comeback Story' Plus Nike, AbbVie And Oracle: CNBC's 'Final Trades'
March 24, 2023
Via
Benzinga
3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence
March 24, 2023
Via
The Motley Fool
Price Over Earnings Overview: AbbVie
March 22, 2023
Via
Benzinga
This Is What Whales Are Betting On AbbVie
March 17, 2023
Via
Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
March 16, 2023
Via
Benzinga
2 High-Yield Dividend Stocks You Won't Regret Buying Right Now
March 23, 2023
Via
The Motley Fool
Use These 3 Strategies to Make $1,000 in Passive Income Per Year
March 23, 2023
Via
The Motley Fool
AbbVie Provides Regulatory Update On Parkinson's Disease Drug Candidate
March 22, 2023
Via
Benzinga
These 3 Dividend Growers Yield More Than the 10-Year Note
March 22, 2023
Via
MarketBeat
Topics
Bonds
Exposures
Debt Markets
4 Top Value Stock ETFs for Long-Term Wealth Building
March 19, 2023
Via
The Motley Fool
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
March 16, 2023
Via
Investor's Business Daily
2 Growth Stocks to Buy Before the Bull Market Arrives
March 16, 2023
Via
The Motley Fool
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
March 15, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.